Sprifermin (AS902330) in Cartilage Injury Repair (CIR)

NCT01066871 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

74

Enrollment

INDUSTRY

Sponsor class

Stopped The study was discontinued due to low recruitment.

Conditions

Isolated Cartilage Injury of the Knee

Interventions

DRUG: Sprifermin (AS902330) 10 mcg
DRUG: Sprifermin (AS902330) 30 mcg
DRUG: Sprifermin (AS902330) 100 mcg
OTHER: Placebo

Sponsor

Merck KGaA, Darmstadt, Germany